Related Experiment Video
Updated: Jul 19, 2025
08:44
Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
6.1K
Eosinophil Phenotypes Are Functionally Regulated by Resolvin D2 during Allergic Lung Inflammation.
Thayse R Brüggemann1, Hong Yong Peh1, Luciana P Tavares1
1Pulmonary and Critical Care Medicine, Department of Internal Medicine.
American Journal of Respiratory Cell and Molecular Biology
|August 8, 2023
Summary
Eosinophils (Eos) are diverse immune cells. Resolvin D2 (RvD2) reduces Eos in allergic lung inflammation by controlling their recruitment and activation, aiding inflammation resolution.
Area of Science:
- Immunology
- Cell Biology
- Respiratory Medicine
Background:
- Eosinophils (Eos) are immune cells found in various organs, exhibiting plasticity.
- Their precise roles and regulation during inflammation are not fully understood.
Purpose of the Study:
- To characterize eosinophil subsets and their regulation during allergic lung inflammation.
- To investigate the effects of resolvin D2 (RvD2) on eosinophil dynamics.
Main Methods:
- Utilized a murine model of allergic lung inflammation.
- Identified eosinophil subsets using CD101 expression.
- Analyzed spatiotemporal localization and transcriptional signatures.
- Assessed the impact of RvD2 on eosinophil numbers, phenotype, and activation.
Main Results:
- Identified two distinct eosinophil subsets (CD101low and CD101high) with different locations and transcriptional profiles.
- CD101low Eos were vascular and infiltrated the interstitium upon challenge; CD101high Eos were inflammatory and activated.
- RvD2 reduced total Eos by inhibiting CD101low Eos recruitment and their differentiation into CD101high Eos.
Conclusions:
- Eosinophils represent a heterogeneous population with distinct activation states and spatiotemporal regulation.
- RvD2 effectively resolves inflammation by modulating eosinophil recruitment and activation pathways.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:20Asthma: Pathogenesis and Management
446
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
446
01:19Antiasthma Drugs: Leukotriene Modifiers
357
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
357
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
346
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
346
02:06Allergic Reactions
27.8K
Overview
27.8K
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K